Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: III. Lack of association of CYP3A4 and CYP2D6 gene polymorphisms

Tiwari, Arun K.; Deshpande, Smita N.; Rao, A.R.; Bhatia, Triptish; Lerer, Bernard; Nimgaonkar, Vishwajit L. and Thelma, B.K. (2005) Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: III. Lack of association of CYP3A4 and CYP2D6 gene polymorphisms. Schizophrenia Research, 75. pp. 21-26.

Full text available as:

PDF - Requires Adobe Acrobat Reader or other PDF viewer.
102 Kb

Abstract

Tardive dyskinesia is a severe debilitating movement disorder characterized by choreoathetotic movements developing in one-fifth of the patients with schizophrenia. In this study we have investigated the significance of CYP3A4*1B and CYP2D6*4 polymorphisms in TD susceptibility among chronic schizophrenia patients (n=335) from north India. Tardive dyskinesia was diagnosed in ~29% (96/335) of these patients. No significant association of either of the two SNPs with TD (CYP3A4*1B v2=0. 308, df=1, p=0.579; CYP2D6*4 v2=0.006, df=1, p=0.935) was observed. However a trend towards increased severity of TD in patients heterozygous for the CYP2D6*4 mutation was observed. D 2005 Elsevier B.V. All rights reserved.

EPrint Type:Article
Uncontrolled Keywords: Tardive dyskinesia; Single nucleotide polymorphism; Association; CYP2D6; CYP3A4; Pharmacogenetics
Subjects:Biological Sciences > Pharmacology
Mental Disorders > Schizophrenia and Disorders with Psychotic Features
Genetic Phenomena > Variation (Genetics)
Nervous System Diseases > Neurologic Manifestations > Dyskinesias
Health Occupations > Pharmacology
ID Code:2181
Deposited By:Dr Triptish Bhatia
Deposited On:07 June 2007

Archive Staff Only: edit this record